Streetbeat News

Stock Prices

CERS

Trading for CERS was halted but has now resumed as of 8:25:00 AM ET, following an update on its status.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:25 pm

SEEL

Seelos Therapeutics announced that its study failed to meet statistical significance in both primary and secondary endpoints in the full analysis set, indicating a setback in its research progress.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 12:21 pm

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares dropped in premarket trading on Tuesday following a 6% rally the previous session. The decline is attributed to several factors including a 6.8% week-over-week decrease in weekly insurance registrations for Tesla vehicles in China, a critical market for Tesla. This downturn in Chinese market performance, coupled with broader market weakness and anticipation of the Federal Reserve's interest rate decisions, has negatively impacted investor sentiment. Analysts are concerned that Tesla's first-quarter deliveries may not meet consensus expectations, further contributing to the stock's premarket decline.

Portfolio Pulse from Shanthi Rexaline

March 19, 2024 | 12:20 pm

NVDA

At GTC 2024, Nvidia Corp (NASDAQ:NVDA) unveiled its next-generation Blackwell GPU and B200 chipset, showcasing significant advancements in AI, data center acceleration, and networking infrastructure. Despite these announcements, NVDA's stock saw a modest increase of 0.70% on the day, with a 1.42% dip in post-market trading. JPMorgan analyst Harlan Sur reiterated an Overweight rating on NVDA, with a price target of $850, highlighting Nvidia's strong positioning in AI, high-performance computing, gaming, and autonomous vehicles. Sur emphasized Nvidia's technological leadership and expansion into the humanoid robots market, maintaining a positive investment outlook.

Portfolio Pulse from Surbhi Jain

March 19, 2024 | 12:15 pm

NHI

PCH

Wall Street's most accurate analysts recommend holding three real estate stocks with over 4% dividend yields: PotlatchDeltic Corporation (PCH), Healthcare Realty Trust Incorporated (HR), and National Health Investors, Inc. (NHI). These recommendations come amidst market turbulence, with recent company performances influencing analyst ratings and price targets.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 12:13 pm

FUSN

GWAV

LICY

OTRK

ZCAR

Fusion Pharmaceuticals Inc. (FUSN) shares surged approximately 95% in pre-market trading after AstraZeneca announced its acquisition of the company for about $2 billion in cash. Other stocks showed significant movement in pre-market trading, with notable gainers including Ontrak, Inc. (OTRK), Zoomcar Holdings, Inc. (ZCAR), and Li-Cycle Holdings Corp. (LICY), among others. Conversely, several stocks experienced declines, such as Greenwave Technology Solutions, Inc. (GWAV), JOANN Inc. (JOAN), and ShiftPixy, Inc. (PIXY).

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 12:11 pm

HUYA

HUYA Inc (NYSE:HUYA) shares dropped after reporting Q4 FY23 revenue of $215.5 million, surpassing expectations but revealing a decline in live streaming revenues and a slight increase in paying users. The company announced a special cash dividend of $0.66 per share, with a stable user base and plans for diversification and strategic transformation.

Portfolio Pulse from Lekha Gupta

March 19, 2024 | 12:09 pm

GUTS

IVP

MTEM

PACB

The article highlights the top 5 oversold health care stocks, which could be potential buys due to their undervalued status. These include Molecular Templates, Inc. (MTEM), Fractyl Health, Inc. (GUTS), Inspire Veterinary Partners, Inc. (IVP), Outset Medical, Inc. (OM), and Pacific Biosciences of California, Inc. (PACB), all of which have an RSI near or below 30, indicating they are oversold.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 12:08 pm

AAPL

GOOG

GOOGL

Apple Inc. has acquired Canadian AI startup DarwinAI to enhance its AI capabilities for future iPhone and iPad features, codenamed 'Project Graymatter'. This project, set to debut with iOS 18, focuses on generative AI features separate from Google's Gemini AI models. Apple's strategic acquisitions in the AI space, including DarwinAI, aim to position it as a leader in personalized AI technology. The company's stock saw a slight increase followed by a minor decrease in premarket trading.

Portfolio Pulse from Rounak Jain

March 19, 2024 | 12:06 pm

GIS

General Mills, Inc. (NYSE:GIS) is anticipated to release its Q3 earnings on March 20, 2024, with expected earnings of $1.05 per share and projected revenue of $4.96 billion. The company recently announced the retirement of Shawn O'Grady, Group President, North America Foodservice. General Mills offers a dividend yield of 3.48%, equating to a quarterly dividend of 59 cents a share. To earn a monthly dividend income of $500, an investor would need to own approximately 2,542 shares, valued around $172,195. The article also explains how dividend yield can fluctuate with stock price and dividend payment changes. GIS shares rose 1.5% to close at $67.74 recently.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 12:03 pm